Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025).
- DOI
- 10.1515/dmpt-2025-0081
- Published
- 2026 Jun 1
- Container
- Drug metabolism and personalized therapy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1515/dmpt-2025-0081,
title = {Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025).},
author = {Miranda A and Lopez C and Santos S and Moncayo A and Morales F and Teran E},
year = {2026},
journal = {Drug metabolism and personalized therapy},
doi = {10.1515/dmpt-2025-0081},
url = {https://doi.org/10.1515/dmpt-2025-0081}
}RIS
TY - JOUR TI - Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025). AU - Miranda A AU - Lopez C AU - Santos S AU - Moncayo A AU - Morales F AU - Teran E PY - 2026 JO - Drug metabolism and personalized therapy DO - 10.1515/dmpt-2025-0081 UR - https://doi.org/10.1515/dmpt-2025-0081 ER -
APA
A, M., C, L., S, S., A, M., F, M., & E, T. (2026). Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025).. Drug metabolism and personalized therapy. https://doi.org/10.1515/dmpt-2025-0081
Source records
- pubmed · retrieved 2026-09-26T01:46:06.532Z
- europe-pmc · retrieved 2026-09-26T01:46:06.549Z